I was very impressed with how well things went at the SHM, especially with all Dr. Lanza's comments. He lent a whole new scientific/future vision to those listening and, imo, commands better speaking skills than Rabin.
For those listening carefully, it should become painfully obvious that ACTC is far, far more than a one trick biotech company focusing on eye diseases.
It really is hard to contain one's excitement over future developments/partnerships/application promise this company has before it.
It's crucial now, imo, for a top ceo to emerge from this search.
Time and again, companies fall far short of what they could be, with less than stellar management.
I would think the incredible potential of ACTC and it's progress to date, would attract top tier talent and hopefully the ACTC Board has been able to articulate those strengths and characteristics that a new ceo needs to bring to the table for all this to happen at this time in the company's growth.
Market Data 
Markets 
AI
